MHRA-101156-PIP01-23

Key Facts

Active Substance
  • Cagrilintide
  • SEMAGLUTIDE
Invented Name
Not available at present
PIP Number MHRA-101156-PIP01-23
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Solution for injection in pre-filled pen
Therapeutic area
Therapeutic area:
  • Endocrinology-Gynaecology-Fertility-metabolism
Conditions / Indications
Conditions / Indications:
  • Type 2 Diabetes mellitus
Route(s) of administration
Route(s) of administration:
  • Subcutaneous use
PIP applicant
Decision Type
Decision Type
W: decision granting a waiver in all age groups for the listed condition(s).
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):Cagrilintide SEMAGLUTIDE.pdf
Published Date 24/06/2024